In a patient with rheumatoid arthritis presenting with iron‑deficiency anemia, what underlying cause should be suspected?

Iron Deficiency Anemia in Rheumatoid Arthritis: What to Suspect

In a patient with rheumatoid arthritis presenting with iron deficiency anemia, you must suspect and investigate for gastrointestinal bleeding as the primary underlying cause, while also recognizing that the chronic inflammatory state itself contributes to iron deficiency through hepcidin-mediated mechanisms.

Dual Pathophysiology: Two Distinct Mechanisms

The anemia in RA patients has two key components that often coexist:

1. True Iron Deficiency (Absolute)

• GI bleeding is the most common culprit 1
  • In one study of 90 RA patients with iron deficiency anemia, 25 had GI bleeding when investigated
  • NSAIDs and antiplatelet agents commonly used in RA increase bleeding risk
  • Malignancy was present in 10% of anemic RA patients, with premalignancy in another 10% 1

2. Functional Iron Deficiency from Chronic Inflammation

• The inflammatory state in RA increases hepcidin production
• Hepcidin blocks iron absorption and mobilization from stores
• This creates "functional" iron deficiency even when total body iron stores may be adequate 2

Critical Diagnostic Approach

Confirm True Iron Deficiency First

The inflammatory state in RA makes standard iron parameters unreliable:

• Ferritin cutoff must be higher: Use ferritin <100 μg/L (not the standard <45 μg/L) to diagnose iron deficiency in the setting of inflammation 2
• Add transferrin saturation: <20% supports iron deficiency 2
• MCV, serum iron, and TIBC have limited diagnostic value in RA patients 3
• When in doubt, bone marrow iron stores remain the gold standard 4, 5

Mandatory GI Investigation

You must perform bidirectional endoscopy (upper and lower) in RA patients with confirmed iron deficiency anemia 6:

• This applies even if the patient is young or premenopausal
• The high prevalence of GI pathology (including malignancy) in this population justifies aggressive investigation
• Do not assume the anemia is simply from chronic disease without excluding GI sources

Additional Testing to Consider

• H. pylori testing: Non-invasive testing followed by treatment if positive 6
• Celiac disease serology: Celiac is a recognized cause of IDA even in asymptomatic patients; perform small bowel biopsy only if serology is positive 6
• Assess disease activity: Higher DAS28 scores, elevated ESR/CRP correlate with anemia severity 7

Common Pitfalls to Avoid

1. Don't assume "anemia of chronic disease" without investigation: In one study, only 64% had pure anemia of chronic disease; 36% had true iron deficiency requiring different management 1

2. Don't use standard ferritin cutoffs: The inflammatory state falsely elevates ferritin; a level of 50-100 μg/L may still represent iron deficiency in RA 2

3. Don't skip endoscopy in younger patients: The combination of NSAID use, antiplatelet therapy, and RA itself creates significant GI bleeding risk regardless of age 1

4. Don't rely on red cell indices alone: MCV, MCH, and MCHC have poor diagnostic power in distinguishing iron deficiency from anemia of chronic disease in RA 5, 3

Treatment Implications

Once GI pathology is excluded or treated:

• Optimize RA disease control: Reducing inflammation improves anemia 7
• Consider intravenous iron: Oral iron absorption is impaired by inflammation and hepcidin elevation 2
• Monitor response: If anemia persists despite iron replacement and improved disease control, reassess for occult bleeding or other causes

The key message: Iron deficiency anemia in RA is multifactorial (60% have iron deficiency per recent data 8), but GI bleeding is the most serious and treatable cause that must not be missed 1.